ATPS-79NOVEL MITOCHONDRIAL BASED CHEMOTHERAPY USING GLIOMA SPECIFIC MITOCHONDRIAL TARGETED DRUGS
نویسندگان
چکیده
منابع مشابه
Investigating mitochondrial radical production using targeted probes.
A range of mitochondria-targeted probe molecules that comprise a lipophilic cation covalently attached to an active moiety have been developed. The lipophilic cation causes the accumulation of these molecules into mitochondria, driven by the mitochondrial membrane potential. To date, we have targeted antioxidants, spin traps, thiol reagents and DNA-alkylating compounds to mitochondria. The sele...
متن کاملMitochondrial toxicity of drugs
my expression of gratitude for giving me the possibility to work on a doctoral thesis in your lab. It has been very interesting to work under the guidance of such a motivating and inspiring person as you. I also would like to thank you for your support in times when everything did not turn out as planned. In the very first year of my thesis I was very fortunate to be guided by Dr. Michael Török...
متن کاملRNA nanotechnology breakthrough for targeted release of RNA-based drugs using cell-based aptamers
Nucleic acids play different roles besides storing information and proteins coding. For example, single-stranded nucleic acids can fold into complicated structures with capability of molecular detection, catalyzing bioreactions and therapy. The development of RNA-based therapies has been rapidly progressed in the recent years. RNA aptamers are biomolecules with a size of 10 to 50 nm that can be...
متن کاملDrugs interfering with mitochondrial disorders.
OBJECTIVES Treatment of mitochondrial disorders (MIDs) is a challenge, since there is no causal therapy available and since there are few studies available, which demonstrate an effect of any agents offered for symptomatic or supportive therapy. Treatment of MIDs is based on five main columns, including symptomatic measures, application of supportive agents, dietary measures, physiotherapy, and...
متن کاملMitochondrial Drugs for Alzheimer Disease
Therapeutic strategies for Alzheimer disease (AD) have yet to offer a disease-modifying effect to stop the debilitating progression of neurodegeneration and cognitive decline. Rather, treatments thus far are limited to agents that slow disease progression without halting it, and although much work towards a cure is underway, a greater understanding of disease etiology is certainly necessary for...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-Oncology
سال: 2015
ISSN: 1522-8517,1523-5866
DOI: 10.1093/neuonc/nov204.79